CERO THERAPEUTICS HOLDINGS, INC. Derivative Liability
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Derivative Liability of $20.00 thousand as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2026-04-15
- 2025-12-31: Derivative Liability $20.00K.
- 2025-09-30: Derivative Liability $20.00K.
- 2024-12-31: Derivative Liability $20.00K.
- 2024-09-30: Derivative Liability $30.00K.
| Period end | Derivative Liability |
|---|---|
| 2025-12-31 | $20.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $20.00K 10-Q · filed 2025-11-19 |
| 2024-12-31 | $20.00K 10-K · filed 2026-04-15 |
| 2024-09-30 | $30.00K 10-Q · filed 2025-11-19 |
| 2024-06-30 | $200.00K 10-Q · filed 2025-11-19 |
| 2024-03-31 | $3.10M 10-Q · filed 2024-05-17 |
| 2024-02-14 | $4.90M 10-K · filed 2026-04-15 |
| 2023-12-31 | $320.12K 10-K · filed 2026-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |